Akribion Therapeutics

Biotechnology

Overview

Akribion Therapeutics is developing a unique, RNA-guided, nuclease-based technology for programmable cell depletion. Founded in 2024 and based in Zwingenberg, Germany, Akribion was spun out of BRAIN Biotech AG.

Funding and backers

Latest round
Venture round
Oct 2024 · 2 yr ago
Backers
2
High-Tech Gründerfonds, BMH Beteiligungs-Managementgesellschaft Hessen
The money's age
Due for its next round
24 months since the last round · not hiring
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Oct 31, 2024 Raised a round Venture round 2024 Founded
Funding rounds
RoundDateAmountInvestorsSource
Venture round Oct 2024 — — handelsregister.de
Registers and programsofficial lists and records that name the company
Legal entity Publications Akribion Therapeutics GmbH its site
Registered 15 Mar 2024
Backed byfrom the funds' portfolios and accelerator catalogs
High-Tech Gründerfonds fund BMH Beteiligungs-Managementgesellschaft Hessen fund
Investors in similar startupsfunds that back the companies most like this one
Insight Partners
backs Chemify
Kleiner Perkins
backs Arsenal Bio
Octopus Ventures
backs Pencil Biosciences Seed
DCVC
backs Chemify
ARCH Venture Partners
backs Arsenal Bio
Future Planet Capital
backs Pencil Biosciences Seed
Similar startupsby what they do, their industry and backers
Alveron PharmaSeed $5.4M · 23 mo ago · 11-50 employees
Alveron Pharma is developing a unique coagulationplatform technology with the world.
Draupnir BioSeed $13M · 2 yr ago
Draupnir Bio is developing new innovative therapies for patients.
ProQR51-200 employees
ProQR is a biotech company that discovers and develops unique RNA therapies for severe rare and common diseases, based in Leiden, The…
Pencil Biosciences SeedVenture round · 3 yr ago · Founded 2018
Pencil Biosciences is pioneering the next generation of gene editing. We are developing a fully synthetic, RNA-guided platform designed to…
ChemifyVenture round · 3 mo ago · Founded 2022
Chemify builds a programmable chemistry platform that turns digital molecule designs into synthesis. Its chemputer robots execute code…
Arsenal Bio
Arsenal Biosciences, Inc. is a clinical stage, programmable cell therapy company focused on solid tumor cell therapies to defeat cancer.

Financials

Latest round
Venture - Series Unknown
Funding rounds
1
Funding rounds
Round Announced Amount
Venture - Series Unknown 2024 — Details

Connections

List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors2
BMH Beteiligungs-Managementgesellschaft HessenVia a fund
29 portfolio companies: Wingcopter, getyond.com, Vidar Sport GmbH and 26 more
High-Tech GründerfondsVia a fund
517 portfolio companies
Report a mistake